12-LO Antibodies

Santa Cruz Biotechnology features a diverse variety of 12-LO Antibodies for advanced research in lipid metabolism and signaling. 12-LO Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 12-lipoxygenase (12-LO) is an enzyme that plays a critical role in the metabolism of arachidonic acid, leading to the production of bioactive lipid mediators involved in inflammation and cell signaling. The regulation of 12-LO is essential for maintaining cellular homeostasis and has implications in various physiological and pathological processes, including cardiovascular diseases and cancer. Understanding the function of 12-LO and its associated pathways can provide insights into therapeutic targets for these conditions. 12-LO research has revealed significant connections between lipid metabolism and inflammatory responses in multiple disease states. Investigating 12-LO activity has led to breakthroughs in understanding cellular stress responses and potential therapeutic interventions. The role of 12-LO in disease progression continues to be an active area of research, with new findings emerging regularly. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of 12-LO's role in human health and disease treatment strategies.